Discuss various investigations done in neurological disorders in detail
Reading Document
Medical Text Search
neurological investigations cerebrospinal fluid analysis EEG nerve conduction studies
Medical Text Search
neuroimaging MRI CT scan PET SPECT neurological disorders
GradeResponse
GradeResponse
Medical Text Search
lumbar puncture CSF analysis neurological disease meningitis encephalitis
Medical Text Search
electroencephalogram EEG epilepsy brain wave recording interpretation
Here is a comprehensive discussion of investigations used in neurological disorders:
Investigations in Neurological Disorders
Neurological investigations are broadly categorized into neuroimaging, electrophysiological studies, cerebrospinal fluid (CSF) analysis, neuropsychological tests, laboratory/blood investigations, and specialized/genetic tests. Selecting the right investigation depends on the clinical syndrome, differential diagnosis, and the neuroanatomical localization.
1. Neuroimaging
A. Computed Tomography (CT) Scan
Principle: X-ray beams rotate around the patient; detectors measure attenuation differences to reconstruct cross-sectional images.
Uses in Neurology:
- First-line in acute stroke (to exclude hemorrhage before thrombolysis)
- Detection of intracranial hemorrhage (hyperdense lesions) — subarachnoid, subdural, extradural, intracerebral
- Skull fractures, cerebral edema, hydrocephalus
- Brain tumors (primary and metastatic)
- Trauma assessment
Advantages:
- Fast (minutes), widely available, cost-effective
- Best for acute hemorrhage and bony structures
Disadvantages:
- Ionizing radiation
- Poor soft tissue resolution compared to MRI
- Cannot detect early ischemic stroke (within first 6 hours)
Special CT techniques:
| Technique | Application |
|---|---|
| CT Angiography (CTA) | Visualizes cerebral vasculature, aneurysms, AVM, carotid stenosis |
| CT Perfusion | Penumbra vs. core infarct in acute stroke |
| CT Myelography | Spinal cord compression, CSF fistula |
B. Magnetic Resonance Imaging (MRI)
Principle: Uses magnetic fields and radiofrequency pulses; different sequences detect different tissue properties.
Core Sequences and Uses:
| Sequence | Best For |
|---|---|
| T1-weighted | Normal anatomy, hemorrhage (subacute), gadolinium contrast enhancement |
| T2-weighted | White matter lesions, edema, demyelination, gliosis |
| FLAIR (Fluid-Attenuated Inversion Recovery) | MS plaques, subarachnoid blood, cortical lesions (suppresses CSF signal) |
| DWI (Diffusion-Weighted Imaging) | Acute ischemic stroke within minutes to hours; also abscess |
| ADC Map | Differentiates true from pseudo-restriction (confirms cytotoxic edema) |
| GRE/SWI (Gradient Echo/Susceptibility Weighted) | Microhemorrhages, cerebral amyloid angiopathy, cavernomas |
| MR Spectroscopy (MRS) | Metabolite mapping — NAA (neuronal loss), choline (tumor), lactate (ischemia) |
| MR Angiography (MRA) | Non-invasive vascular imaging — aneurysms, arterial stenosis, AVM |
| MR Venography (MRV) | Cerebral venous sinus thrombosis |
| fMRI | Pre-surgical mapping of eloquent cortex (language, motor) |
| DTI (Diffusion Tensor Imaging) | White matter tract integrity; useful in TBI, MS |
| Perfusion MRI | Stroke penumbra mapping |
MRI is superior to CT for:
- Early ischemic stroke
- Posterior fossa lesions (brainstem, cerebellum — CT has artifact here)
- Demyelinating diseases (multiple sclerosis)
- Spinal cord pathology
- Infections (encephalitis, abscess)
- Tumors with detailed characterization
Contraindications: Pacemakers, cochlear implants, certain metallic implants, severe claustrophobia.
C. PET Scan (Positron Emission Tomography)
- Uses radiolabeled tracers (most commonly ¹⁸F-FDG for glucose metabolism)
- FDG-PET: Detects hypometabolism in Alzheimer's disease (temporoparietal), frontotemporal dementia (frontal/temporal), Parkinson's disease
- Amyloid PET (florbetapir/florbetaben): Detects amyloid plaques in Alzheimer's disease — positive years before symptoms
- Tau PET: Detects neurofibrillary tangles in tauopathies
- Dopaminergic PET: Assesses nigrostriatal pathways in Parkinsonism
- PET in Epilepsy: Interictal hypometabolism identifies epileptogenic zone for presurgical evaluation
D. SPECT (Single Photon Emission Computed Tomography)
- Uses gamma-emitting isotopes (e.g., Tc-99m HMPAO for cerebral blood flow)
- DaTSCAN (¹²³I-ioflupane SPECT): Dopamine transporter imaging — differentiates Parkinson's disease (reduced uptake) from essential tremor (normal uptake)
- Ictal SPECT: Captures hyperperfusion at seizure focus
- Used in dementia workup and cerebrovascular disease assessment
E. Cerebral Angiography (Digital Subtraction Angiography — DSA)
- Gold standard for intracranial aneurysms, AVM, vasculitis, cerebral venous thrombosis
- Allows simultaneous therapeutic intervention (coiling of aneurysm, thrombectomy)
- Invasive; risk of stroke ~0.5–1%
2. Electrophysiological Investigations
A. Electroencephalogram (EEG)
Principle: Records spontaneous electrical activity of the brain via scalp electrodes, reflecting cortical neuronal synchrony.
Normal Brain Rhythms:
| Rhythm | Frequency | Significance |
|---|---|---|
| Delta | < 4 Hz | Deep sleep; pathological if awake |
| Theta | 4–8 Hz | Drowsiness; abnormal if excessive in adults |
| Alpha | 8–13 Hz | Relaxed wakefulness (posterior dominant) |
| Beta | > 13 Hz | Active thought, anxiety, benzodiazepines |
| Gamma | > 30 Hz | Cognitive processing |
Clinical Applications:
- Epilepsy: Most important indication
- Interictal spikes, spike-and-wave complexes
- 3 Hz spike-and-wave: absence epilepsy
- Hypsarrhythmia: infantile spasms (West syndrome)
- Burst suppression: severe encephalopathy, barbiturate coma
- Encephalopathy: Diffuse slowing; triphasic waves in hepatic encephalopathy
- Brain death: Electrocerebral silence (isoelectric EEG) — part of confirmatory criteria
- Herpes encephalitis: Periodic lateralized epileptiform discharges (PLEDs) over temporal lobes
- CJD (Creutzfeldt-Jakob Disease): Periodic sharp wave complexes (PSWCs)
- Sleep disorders: Polysomnography (PSG) — extended EEG with EMG, EOG
Special EEG Techniques:
- Ambulatory EEG: 24-hour outpatient recording
- Video-EEG telemetry: Captures ictal semiology + EEG simultaneously — essential for pre-surgical epilepsy evaluation
- Depth/Intracranial EEG (SEEG): Invasive recording for seizure focus localization
B. Nerve Conduction Studies (NCS)
Principle: An electrical stimulus is applied to a nerve; recordings measure latency, amplitude, and conduction velocity.
Types:
- Motor NCS: Stimulate nerve, record from muscle (CMAP — compound muscle action potential)
- Sensory NCS: Record orthodromic or antidromic sensory potentials (SNAP — sensory nerve action potential)
- F-waves: Assess proximal nerve conduction (e.g., nerve roots)
- H-reflex: Electrophysiological equivalent of ankle jerk; tests S1 root
Key Parameters:
| Parameter | Demyelination | Axonal Loss |
|---|---|---|
| Conduction velocity | Reduced | Normal or mildly reduced |
| Distal latency | Prolonged | Normal |
| Amplitude (CMAP/SNAP) | Normal or mildly reduced | Significantly reduced |
| Conduction block | Present | Absent |
Applications:
- Peripheral neuropathy: Differentiates demyelinating (e.g., GBS, CIDP) vs. axonal (e.g., diabetic, toxic) neuropathies
- Carpal tunnel syndrome: Prolonged median nerve distal latency
- Ulnar neuropathy, radial nerve palsy
- Guillain-Barré Syndrome (GBS): Absent F-waves, prolonged latencies early
- CIDP: Conduction block, temporal dispersion
C. Electromyography (EMG)
Principle: Records electrical activity from muscle fibers using a needle electrode.
Findings:
| Finding | Significance |
|---|---|
| Fibrillation potentials | Denervation (axonal loss or anterior horn cell disease) |
| Positive sharp waves | Denervation |
| Fasciculations | Lower motor neuron disease (e.g., ALS) |
| Reduced recruitment | LMN lesion |
| Myopathic MUPs (small, polyphasic) | Myopathy (e.g., polymyositis, muscular dystrophy) |
| Neurogenic MUPs (large, polyphasic) | Reinnervation after axonal loss |
| Myotonic discharges | Myotonic dystrophy, myotonia congenita |
Applications:
- Localization of lesion: anterior horn cell, nerve root, plexus, peripheral nerve, NMJ, or muscle
- ALS: widespread denervation in limbs + bulbar + thoracic regions
- Distinguishes neuropathy from myopathy
- Radiculopathy: denervation in specific myotome
D. Evoked Potentials (EPs)
Record the brain's electrical response to a specific sensory stimulus.
| Type | Stimulus | Pathway Tested | Clinical Use |
|---|---|---|---|
| VEP (Visual Evoked Potential) | Pattern reversal checkerboard | Optic nerve / visual cortex | Multiple sclerosis (delayed P100) |
| BAEP (Brainstem Auditory EP) | Clicks | Auditory pathway to brainstem | Acoustic neuroma, brainstem lesions, hearing assessment |
| SSEP (Somatosensory EP) | Peripheral nerve electrical stimulation | Dorsal column-medial lemniscal | Spinal cord integrity, MS, intraoperative monitoring |
| MEP (Motor Evoked Potential) | Transcranial magnetic stimulation | Corticospinal tract | ALS, MS, spinal cord monitoring |
E. Repetitive Nerve Stimulation (RNS)
- Tests neuromuscular junction (NMJ) function
- Decremental response (>10% at low frequency 3 Hz): Myasthenia Gravis
- Incremental response at high frequency (>100%): Lambert-Eaton Myasthenic Syndrome (LEMS)
3. Cerebrospinal Fluid (CSF) Analysis
Obtained via lumbar puncture (LP) at L3–L4 or L4–L5 interspace.
Contraindications to LP:
- Raised intracranial pressure (papilledema) — risk of herniation; CT must be done first
- Coagulopathy / anticoagulation
- Skin infection over puncture site
- Spinal cord compression
Normal CSF Values:
| Parameter | Normal |
|---|---|
| Appearance | Crystal clear, colorless |
| Pressure | 70–180 mmH₂O |
| Cells | 0–5 lymphocytes/mm³ |
| Protein | 15–45 mg/dL |
| Glucose | 45–80 mg/dL (>60% of serum glucose) |
CSF Findings in Key Neurological Diseases:
| Disease | Cells | Protein | Glucose | Other |
|---|---|---|---|---|
| Bacterial meningitis | High (PMNs, 100s–1000s) | Very high | Low | Culture +ve, Gram stain |
| Viral (aseptic) meningitis | Lymphocytes (10s–100s) | Mildly elevated | Normal | PCR for specific virus |
| TB meningitis | Lymphocytes | High | Very low | AFB smear/culture, ADA elevated |
| Fungal meningitis | Lymphocytes | High | Low | India ink, cryptococcal antigen |
| Herpes encephalitis | Lymphocytes + RBCs | Elevated | Normal | HSV PCR |
| Subarachnoid hemorrhage | Uniformly bloody → xanthochromia | Elevated | Normal | Xanthochromia after 2–4 hours |
| GBS | Albuminocytological dissociation | Very high | Normal | Cells normal/mildly elevated |
| MS | Oligoclonal bands (>95%), lymphocytes ≤50 | Mildly elevated | Normal | Elevated IgG index |
| CJD | Normal | Mildly elevated | Normal | 14-3-3 protein, RT-QuIC assay |
| Neurosyphilis | Lymphocytes | Elevated | Low/Normal | VDRL in CSF +ve |
| Normal pressure hydrocephalus | Normal | Normal | Normal | Elevated opening pressure |
Special CSF Tests:
- Oligoclonal bands (OCBs): MS diagnosis — detected by isoelectric focusing
- 14-3-3 protein: CJD
- RT-QuIC (Real-Time Quaking-Induced Conversion): Highly sensitive for prion disease
- Cytology: Leptomeningeal carcinomatosis (malignant cells)
- Flow cytometry: Lymphoma/leukemia involving CNS
- Beta-2 transferrin: CSF rhinorrhea/otorrhea diagnosis
- Autoimmune antibodies in CSF: Anti-NMDAR (NMDA receptor encephalitis), anti-LGI1, anti-CASPR2
4. Neuropsychological Testing
Used to assess cognitive domains objectively:
| Test | Domain Assessed |
|---|---|
| Mini-Mental State Exam (MMSE) | Global cognition screening |
| Montreal Cognitive Assessment (MoCA) | Mild cognitive impairment detection |
| Clock Drawing Test | Visuospatial, executive function |
| Trail Making Test A & B | Processing speed, executive function |
| Rey Auditory Verbal Learning Test | Memory encoding and recall |
| Frontal Assessment Battery (FAB) | Frontal lobe / executive function |
| Digit Span | Working memory, attention |
| Boston Naming Test | Language/naming |
| Wisconsin Card Sorting | Frontal/executive function |
Conditions assessed: Alzheimer's disease, frontotemporal dementia, vascular dementia, MCI, traumatic brain injury, neurodevelopmental disorders.
5. Laboratory (Blood) Investigations
Routine:
- CBC: Anemia (hyperviscosity stroke), thrombocytopenia (bleeding), infection
- ESR, CRP: CNS vasculitis, infection
- Serum electrolytes: Hypo/hypernatremia causes encephalopathy, seizures
- Blood glucose (stat): First step in altered consciousness; hypoglycemia mimics stroke
- Renal and hepatic function: Metabolic encephalopathy
- Coagulation profile: Hemorrhagic/thromboembolic stroke risk
- Thyroid function (TSH, FT4): Hypothyroid myopathy, Hashimoto's encephalopathy
Specific Neurological Blood Tests:
| Test | Indication |
|---|---|
| Vitamin B12 | Subacute combined degeneration of cord, neuropathy, dementia |
| Homocysteine | Stroke risk factor, B12/folate deficiency |
| Serum folate | Neural tube defects, neuropathy |
| Creatine Kinase (CK) | Myopathy, myositis, rhabdomyolysis |
| Serum lactate/pyruvate | Mitochondrial disorders |
| Serum ammonia | Hepatic encephalopathy |
| ANA, ANCA, anti-dsDNA | CNS vasculitis, SLE |
| Antiphospholipid antibodies | Stroke in young, thrombosis |
| VDRL/RPR + TPHA | Neurosyphilis |
| HIV | HIV-associated neurocognitive disorders, opportunistic infections |
| Serum ACE | Neurosarcoidosis |
| Paraneoplastic antibodies | Anti-Hu, anti-Yo, anti-Ri — paraneoplastic syndromes |
| Autoimmune encephalitis antibodies | Anti-NMDAR, anti-LGI1, anti-CASPR2, anti-AMPAR, anti-GABA-B |
| Acetylcholine receptor (AChR) antibodies | Myasthenia Gravis |
| Anti-MuSK antibodies | Seronegative MG |
| Anti-VGCC antibodies | Lambert-Eaton syndrome |
| Ceruloplasmin + serum copper | Wilson's disease |
| Alpha-fetoprotein | Ataxia-telangiectasia |
| Very long chain fatty acids | Adrenoleukodystrophy |
| Lysosomal enzyme assays | Storage disorders (Gaucher, Fabry, Niemann-Pick) |
6. Genetic and Molecular Investigations
| Test | Use |
|---|---|
| Chromosomal karyotype | Chromosomal disorders (Down syndrome, Turner) |
| FISH (Fluorescence In Situ Hybridization) | Microdeletion/duplication syndromes |
| PCR-based tests | Trinucleotide repeat disorders (Huntington's, myotonic dystrophy, Friedreich's ataxia, SCA subtypes) |
| Array CGH (Comparative Genomic Hybridization) | Autism, intellectual disability |
| Whole Exome Sequencing (WES) | Rare/undiagnosed neurogenetic diseases |
| Whole Genome Sequencing (WGS) | Comprehensive genetic analysis |
| APOE genotyping | Alzheimer's disease risk stratification |
| LRRK2, PINK1, Parkin, SNCA | Familial Parkinson's disease |
| SOD1, C9orf72, TARDBP, FUS | Familial ALS |
| NOTCH3 (CADASIL) | Hereditary stroke/white matter disease |
| Mitochondrial DNA analysis | MELAS, MERRF, Leber's optic neuropathy |
7. Neuro-Ophthalmological Investigations
| Investigation | Indication |
|---|---|
| Fundoscopy | Papilledema (raised ICP), optic atrophy (MS, glaucoma) |
| Visual field testing (perimetry) | Chiasmal and retrochiasmal lesions |
| OCT (Optical Coherence Tomography) | Retinal nerve fiber layer thinning in MS and optic neuritis |
| Pupil assessment | Horner's syndrome, III nerve palsy, Argyll Robertson pupil |
| Slit-lamp | Kayser-Fleischer rings (Wilson's disease) |
8. Neuropathology (Brain Biopsy)
Indications:
- Undiagnosed brain mass/tumor
- Cerebral vasculitis
- Prion disease (definitive diagnosis)
- Encephalitis of unknown etiology
- Leptomeningeal metastasis
Techniques: Stereotactic biopsy (image-guided), open biopsy, meningeal biopsy.
Findings:
- Glioblastoma: pseudopalisading necrosis
- MS: demyelination with relative axonal preservation
- CJD: spongiform change, prion protein deposits
- Granulomas: TB, sarcoidosis
9. Autonomic Nervous System Tests
| Test | Indication |
|---|---|
| Tilt Table Test | Orthostatic hypotension, vasovagal syncope |
| Sudomotor testing (QSART) | Small fiber neuropathy, autonomic neuropathy |
| Heart Rate Variability | Cardiac autonomic function |
| Skin conductance response | Peripheral autonomic neuropathy |
| Bladder urodynamics | Neurogenic bladder (MS, spinal cord disease) |
10. Muscle and Nerve Biopsy
Muscle Biopsy:
- Distinguishes myopathic vs. neurogenic changes
- Special stains: Gomori trichrome (ragged red fibers in mitochondrial myopathy), ATPase (fiber type differentiation), PAS (glycogen storage), Oil Red O (lipid storage)
- Immunohistochemistry: dystrophin staining (absent in Duchenne MD, reduced in Becker MD)
Nerve Biopsy (usually sural nerve):
- Vasculitic neuropathy (fibrinoid necrosis of vessel walls)
- Amyloid neuropathy (Congo red staining, apple-green birefringence)
- CIDP: onion bulb formation (repeated demyelination/remyelination)
- Leprosy: acid-fast bacilli in nerve
Summary Table: Investigation of Choice by Condition
| Condition | Key Investigation(s) |
|---|---|
| Acute ischemic stroke | CT (exclude hemorrhage), MRI DWI, MRA/CTA |
| Subarachnoid hemorrhage | CT non-contrast → LP (xanthochromia) → DSA |
| Epilepsy | EEG, MRI brain, blood glucose/electrolytes |
| Multiple sclerosis | MRI (McDonald criteria), CSF OCBs, VEPs |
| GBS | NCS (demyelinating pattern), CSF (albuminocytological dissociation) |
| Myasthenia Gravis | AChR antibodies, RNS (decrement), edrophonium test |
| Alzheimer's disease | MRI, neuropsychometry, PET (amyloid/FDG) |
| Parkinson's disease | Clinical; DaTSCAN SPECT if doubt |
| Bacterial meningitis | LP urgently; CT first if focal signs/raised ICP |
| Herpes encephalitis | MRI (temporal lobe), HSV PCR in CSF |
| NMDA receptor encephalitis | Anti-NMDAR antibodies (serum + CSF), MRI |
| ALS | EMG (widespread denervation + fasciculations), NCS |
| Myopathy | CK, EMG, muscle biopsy |
| Wilson's disease | Ceruloplasmin, 24h urine copper, KF rings, liver biopsy |
| CJD | MRI (DWI cortical ribboning), EEG (PSWCs), CSF 14-3-3, RT-QuIC |
This framework of investigations, when applied systematically alongside a thorough history and neurological examination, allows accurate diagnosis, disease monitoring, and prognosis in virtually all neurological disorders. The choice of investigation should always be guided by the clinical localization and the likely differential diagnoses.
This is a shared conversation. Sign in to Orris to start your own chat.